Dimers Initiate and Propagate Serine Protease Inhibitor Polymerisation

Journal of Molecular Biology

Volumn 375, Issue 1, 2008, Pages 36-42

  Zhou, Aiwu ^a   Carrell, Robin W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

amyloid; antitrypsin; polymerisation; prions; serpins

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTITHROMBIN; DIMER; MONOMER; OLIGOMER; POLYMER; SERINE PROTEINASE INHIBITOR; TETRAMER;

ARTICLE; BETA SHEET; NERVE DEGENERATION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN POLYMERIZATION; PROTEOMICS; STRUCTURE ANALYSIS;

EID: 36348939332     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.10.055     Document Type: Article

References (44)

1. 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J. Mol. Biol. 177 (1984) 531-556
2. Huntington J.A., Read R.J., and Carrell R.W. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407 (2000) 923-926
3. Schulze A.J., Baumann U., Knof S., Jaeger E., Huber R., and Laurell C.B. Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A. Eur. J. Biochem. 194 (1990) 51-56
4. Mast A.E., Enghild J.J., and Salvesen G. Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis. Biochemistry 31 (1992) 2720-2728
5. 1-antitrypsin accumulation in the liver. Nature 357 (1992) 605-607
6. 1-antitrypsin. Biochemistry 32 (1993) 500-508
7. Huntington J.A., Pannu N.S., Hazes B., Read R.J., Lomas D.A., and Carrell R.W. A 2.6 Å structure of a serpin polymer and implications for conformational disease. J. Mol. Biol. 293 (1999) 449-455
8. Dunstone M.A., Dai W., Whisstock J.C., Rossjohn J., Pike R.N., Feil S.C., et al. Cleaved antitrypsin polymers at atomic resolution. Protein Sci. 9 (2000) 417-420
9. Pedersen K.E., Einholm A.P., Christensen A., Schack L., Wind T., Kenney J.M., and Andreasen P.A. Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligands. Biochem. J. 372 (2003) 747-755
10. Whisstock J.C., and Bottomley S.P. Molecular gymnastics: serpin structure, folding and misfolding. Curr. Opin. Struct. Biol. 16 (2006) 761-768
11. Wilczynska M., Lobov S., Ohlsson P.I., and Ny T. A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization. EMBO J. 22 (2003) 1753-1761
12. Stein P.E., and Carrell R.W. What do dysfunctional serpins tell us about molecular mobility and disease?. Nat. Struct. Biol. 2 (1995) 96-113
13. Crowther D.C., Serpell L.C., Dafforn T.R., Gooptu B., and Lomas D.A. Nucleation of alpha 1-antichymotrypsin polymerization. Biochemistry 42 (2003) 2355-2363
14. Sivasothy P., Dafforn T.R., Gettins P.G., and Lomas D.A. Pathogenic alpha 1-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage. J. Biol. Chem. 275 (2000) 33663-33668
15. McKay E.J. A simple two-step procedure for the isolation of antithrombin III from biological fluids. Thromb. Res. 21 (1981) 375-382
16. Zhou A., Stein P.E., Huntington J.A., and Carrell R.W. Serpin polymerization is prevented by a hydrogen bond network that is centered on his-334 and stabilized by glycerol. J. Biol. Chem. 278 (2003) 15116-15122
17. Zhou A., Huntington J.A., and Carrell R.W. Formation of the antithrombin heterodimer and the onset of thrombosis. Blood 94 (1999) 3388-3396
18. Gooptu B., Hazes B., Chang W.S., Dafforn T.R., Carrell R.W., Read R.J., and Lomas D.A. Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc. Natl Acad. Sci. USA 97 (2000) 67-72
19. Chang W.S., Whisstock J., Hopkins P.C., Lesk A.M., Carrell R.W., and Wardell M.R. Importance of the release of strand 1C to the polymerization mechanism of inhibitory serpins. Protein Sci. 6 (1997) 89-98
20. Fitton H.L., Pike R.N., Carrell R.W., and Chang W.-S.W. Mechanisms of antithrombin polymerisation and heparin activation probed by insertion of synthetic reactive loop peptides. Biol. Chem. 378 (1997) 1059-1063
21. Skinner R., Chang W.S., Jin L., Pei X., Huntington J.A., Abrahams J.P., et al. Implications for function and therapy of a 2.9 Å structure of binary-complexed antithrombin. J. Mol. Biol. 283 (1998) 9-14
22. Zhou A., Stein P.E., Huntington J.A., Sivasothy P., Lomas D.A., and Carrell R.W. How small peptides block and reverse serpin polymerisation. J. Mol. Biol. 342 (2004) 931-941
23. Horvath A.J., Irving J.A., Rossjohn J., Law R.H., Bottomley S.P., Quinsey N.S., et al. The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins. J. Biol. Chem. 280 (2005) 43168-43178
24. Zhou A., Wei Z., Read R.J., and Carrell R.W. Structural mechanism for the carriage and release of thyroxine in the blood. Proc. Natl Acad. Sci. USA 103 (2006) 13321-13326
25. Zhou A., Carrell R.W., and Huntington J.A. The serpin inhibitory mechanism is critically dependent on the length of the reactive center loop. J. Biol. Chem. 276 (2001) 27541-27547
26. James E.L., and Bottomley S.P. The mechanism of alpha 1-antitrypsin polymerization probed by fluorescence spectroscopy. Arch. Biochem. Biophys. 356 (1998) 296-300
27. Dafforn T.R., Mahadeva R., Elliott P.R., Sivasothy P., and Lomas D.A. A kinetic mechanism for the polymerization of alpha1-antitrypsin. J. Biol. Chem. 274 (1999) 9548-9555
28. Devlin G.L., Chow M.K., Howlett G.J., and Bottomley S.P. Acid denaturation of alpha1-antitrypsin: characterization of a novel mechanism of serpin polymerization. J. Mol. Biol. 324 (2002) 859-870
29. Mahadeva R., Dafforn T.R., Carrell R.W., and Lomas D.A. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J. Biol. Chem. 277 (2002) 6771-6774
30. Purkayastha P., Klemke J.W., Lavender S., Oyola R., Cooperman B.S., and Gai F. Alpha 1-antitrypsin polymerization: a fluorescence correlation spectroscopic study. Biochemistry 44 (2005) 2642-2649
31. Chowdhury P., Wang W., Lavender S., Bunagan M.R., Klemke J.W., Tang J., et al. Fluorescence correlation spectroscopic study of serpin depolymerization by computationally designed peptides. J. Mol. Biol. 369 (2007) 462-473
32. Huntington J.A., and Gettins P.G.W. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin. Biochemistry 37 (1998) 3272-3277
33. Carrell R.W., and Lomas D.A. Conformational diseases. Lancet 350 (1997) 134-138
34. Carrell R.W., and Gooptu B. Conformational changes and disease-serpins, prions and Alzheimer's. Curr. Opin. Struct. Biol. 8 (1998) 799-809
35. Davis R.L., Shrimpton A.E., Holohan P.D., Bradshaw C., Feiglin D., Collins G.H., et al. Familial dementia caused by polymerization of mutant neuroserpin. Nature 401 (1999) 376-379
36. Reixach N., Deechongkit S., Jiang X., Kelly J.W., and Buxbaum J.N. Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc. Natl Acad. Sci. USA 101 (2004) 2817-2822
37. Haass C., and Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8 (2007) 101-112
38. Wahlbom M., Wang X., Lindstrom V., Carlemalm E., Jaskolski M., and Grubb A. Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. J. Biol. Chem. 282 (2007) 18318-18326
39. Sanbe A., Osinska H., Villa C., Gulick J., Klevitsky R., Glabe C.G., et al. Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc. Natl Acad. Sci. USA 102 (2005) 13592-13597
40. Diaz-Hernandez M., Moreno-Herrero F., Gomez-Ramos P., Moran M.A., Ferrer I., Baro A.M., et al. Biochemical, ultrastructural, and reversibility studies on huntingtin filaments isolated from mouse and human brain. J. Neurosci. 24 (2004) 9361-9371
41. Calamai M., Canale C., Relini A., Stefani M., Chiti F., and Dobson C.M. Reversal of protein aggregation provides evidence for multiple aggregated states. J. Mol. Biol. 346 (2005) 603-616
42. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., Serpell L., et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289 (2000) 1317-1321
43. Scheibel T., Bloom J., and Lindquist S.L. The elongation of yeast prion fibers involves separable steps of association and conversion. Proc. Natl Acad. Sci. USA 101 (2004) 2287-2292
44. Soto C., Estrada L., and Castilla J. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci. 31 (2006) 150-155